{"id":563832,"date":"2026-09-22T12:30:00","date_gmt":"2026-09-22T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=563832"},"modified":"2026-09-22T13:06:06","modified_gmt":"2026-09-22T11:06:06","slug":"bloqueio-da-interleucina-ou-inibicao-da-ox40-l","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/bloqueio-da-interleucina-ou-inibicao-da-ox40-l\/","title":{"rendered":"Bloqueio da interleucina ou inibi\u00e7\u00e3o da OX40-(L)?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Na patog\u00e9nese da dermatite at\u00f3pica (DA) est\u00e1 envolvida uma cascata complexa que decorre a v\u00e1rios n\u00edveis. Para o tratamento da DA de gravidade moderada a grave, foram desenvolvidas terapias com anticorpos imunomoduladores que interv\u00eam de diversas formas no processo inflamat\u00f3rio. Para al\u00e9m dos medicamentos biol\u00f3gicos que se dirigem contra a interleucina(IL)-31-R-\u03b1, IL-4R-\u03b1 ou, seletivamente, contra a IL-13, est\u00e3o atualmente a ser investigados em ensaios cl\u00ednicos os efeitos dos anticorpos monoclonais que t\u00eam como alvo a via de sinaliza\u00e7\u00e3o OX40-OX40L.<\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fbloqueio-da-interleucina-ou-inibicao-da-ox40-l%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Na patog\u00e9nese da dermatite at\u00f3pica (DA) est\u00e1 envolvida uma cascata complexa que decorre a v\u00e1rios n\u00edveis. Para o tratamento da DA de gravidade moderada a grave, foram desenvolvidas terapias com&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fbloqueio-da-interleucina-ou-inibicao-da-ox40-l%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":563839,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Dermatite at\u00f3pica: abordar os alvos imunol\u00f3gicos com precis\u00e3o","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11551,11344,11356,11521,11524],"tags":[100036,82410,84901,82409,100029,13525,100028,100031,82406,100034,65865,100030,100032,100027,100035,100033,13302],"powerkit_post_featured":[],"class_list":["post-563832","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-alergologia-e-imunologia-clinica","category-dermatologia-e-venereologia-pt-pt","category-estudos","category-formacao-continua","tag-adjoin","tag-advogado","tag-amlitelimab-pt-pt","tag-arcadia-pt-pt","tag-bloqueio-da-interleucina","tag-dupilumab-pt-pt","tag-ecztra","tag-inibicao-da-ox40-l","tag-lebrikizumab-pt-pt","tag-liberty-ad-preschool","tag-nemolizumab-pt-pt","tag-percurso-do-sinal-ox40-ox40l","tag-rocatinlimab","tag-rocket","tag-stapokibart","tag-stream-ad","tag-tralokinumab-pt-pt","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-29 14:31:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":563848,"slug":"bloqueo-de-la-interleucina-o-inhibicion-de-ox40-l","post_title":"\u00bfBloqueo de la interleucina o inhibici\u00f3n de OX40-(L)?","href":"https:\/\/medizinonline.com\/es\/bloqueo-de-la-interleucina-o-inhibicion-de-ox40-l\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/563832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=563832"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/563832\/revisions"}],"predecessor-version":[{"id":566940,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/563832\/revisions\/566940"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/563839"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=563832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=563832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=563832"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=563832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}